These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1736494)

  • 41. Nephrolithiasis and bone involvement in primary hyperparathyroidism.
    Silverberg SJ; Shane E; Jacobs TP; Siris ES; Gartenberg F; Seldin D; Clemens TL; Bilezikian JP
    Am J Med; 1990 Sep; 89(3):327-34. PubMed ID: 2393037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronobiology of urinary citrate excretion amongst stone-formers and healthy males from north western India.
    Wangoo D; Thind SK; Gupta GS; Nath R
    Urol Res; 1991; 19(3):203-6. PubMed ID: 1887530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CITRIC ACID EXCRETION IN RENAL STONE DISEASE AND IN RENAL TUBULAR ACIDOSIS.
    NORDIN BE; SMITH DA
    Br J Urol; 1963 Dec; 35():438-44. PubMed ID: 14077801
    [No Abstract]   [Full Text] [Related]  

  • 44. [Diagnosis of primary hyperparathyroidism in patients with coral-like nephrolithiasis].
    Pavlov AIu; Gusev BS; Nikitinskaia LP
    Urol Nefrol (Mosk); 1983; (4):8-13. PubMed ID: 6623756
    [No Abstract]   [Full Text] [Related]  

  • 45. [Predictive value of lithogenic risk in hypercalciuria: should 24-hour urine calcium be measured?].
    Ulmann A
    Nephrologie; 1984; 5(5):232-4. PubMed ID: 6531063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcium metabolism in renal stone disease.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():111-23. PubMed ID: 6937987
    [No Abstract]   [Full Text] [Related]  

  • 47. Mechanism of allopurinol action in calcium oxalate stone formers.
    Tomlinson B; Al-Khader A; Cohen SL; Kasidas GP; Krywawych S; Edgar L; Rose GA
    Proc Eur Dial Transplant Assoc; 1981; 18():556-60. PubMed ID: 6276882
    [No Abstract]   [Full Text] [Related]  

  • 48. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic versus environmental factors in renal stone disease.
    Jaeger P
    Curr Opin Nephrol Hypertens; 1996 Jul; 5(4):342-6. PubMed ID: 8823532
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hypercalciuria and primary hyperparathyroidism in patients with kidney calculi. II. Primary hyperparathyroidism].
    Nieszporek T; Kokot F; Skrzypek J; Wieczorek M; Kuska J
    Pol Arch Med Wewn; 1992 Jan; 87(1):49-53. PubMed ID: 1641364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Influence of the parathyroid glands on the citrate balance and its significance for bones].
    Mosonyi L
    Wien Z Inn Med; 1969; 50(9):429-35. PubMed ID: 5387509
    [No Abstract]   [Full Text] [Related]  

  • 52. [Calcium and citrate excretion by patients with calculi and healthy probands during induced acidosis].
    Bothor C; Berg W; Donner M; Pirlich W
    Urologe A; 1989 Mar; 28(2):112-5. PubMed ID: 2718293
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and biochemical patterns of presentation in monolateral and bilateral calcium nephrolithiasis.
    Vitale C; Marangella M; Cosseddu D; Tricerri A; Linari F
    Clin Nephrol; 1997 Jan; 47(1):23-7. PubMed ID: 9021237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Milk-of-calcium renal stone in primary hyperparathyroidism.
    Harell GS
    Ann Intern Med; 1969 Mar; 70(3):577-80. PubMed ID: 5775037
    [No Abstract]   [Full Text] [Related]  

  • 55. Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis?
    D'Angelo A; Lodetti MG; Giannini S; Castrignano R; al Awady M; Malvasi L; Fabris A; Maschio G
    Miner Electrolyte Metab; 1992; 18(6):359-64. PubMed ID: 1291857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism.
    Fuss M; Gillet C; Simon J; Vandewalle JC; Schoutens A; Bergmann P
    Eur Urol; 1983; 9(1):32-4. PubMed ID: 6822240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study.
    Mollerup CL; Vestergaard P; Frøkjaer VG; Mosekilde L; Christiansen P; Blichert-Toft M
    BMJ; 2002 Oct; 325(7368):807. PubMed ID: 12376441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of bendroflumethiazide on the intestinal absorption of calcium in normocalcaemic renal stone formers and in hyperparathyroidism.
    Jorgensen FS; Transbol I
    Acta Med Scand; 1974; 195(1-2):33-6. PubMed ID: 4817089
    [No Abstract]   [Full Text] [Related]  

  • 59. [Renal lithiasis as a manifestation of primary hyperparathyroidism].
    Soriano Guillén L; Muñoz Calvo MT; Torrijos Román C; Sánchez-Prieto Emmanuel I; Pozo Román J; Argente Oliver J
    An Esp Pediatr; 2001 Sep; 55(3):277-81. PubMed ID: 11676907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnosis of parathyroid overactivity in a population of renal stone formers.
    Scott R; Dryburgh F; Wilson R; Boyle IT; Pollock D
    Br J Surg; 1972 Jul; 59(7):517-21. PubMed ID: 5041102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.